RESOLVE THERAPEUTICS
DEAD

Serial Number

98928125

Owner

Resolve Therapeutics LLC

Attorney

Demyana Boshra

First Use Date

Jul 15, 2010

Filing Date

Dec 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

RESOLVE THERAPEUTICS Trademark

Serial Number: 98928125

RESOLVE THERAPEUTICS is a trademark filed by Resolve Therapeutics LLC on December 30, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Resolve Therapeutics LLC (3 trademarks)

1951 NW 7th Ave., Suite 300
Miami, FL 33136

Entity Type: 16

Trademark Details

Filing Date

December 30, 2024

Registration Date

Not Registered

First Use Anywhere

July 15, 2010

First Use in Commerce

July 15, 2010

Goods & Services

Medical information services provided via the Internet; Providing medical information; Providing medical information in the field of pharmaceuticals, medicines, autoimmune diseases, and immune-cardiology; Providing medical information in the field of healthcare, health conditions, and diseases

Biological research; Biological research and analysis; Medical research; Medical research laboratories; Medical research laboratory services; Medical research services; Medical and scientific research in the field of autoimmune diseases, immuno-cardiology, chronic inflammations, heart diseases, and new therapies for autoimmune diseases; Providing information about medical and scientific research via a website; Research and development of new products for others; Research and development in the field of autoimmune diseases, immuno-cardiology, chronic inflammations, heart diseases, and new therapies for autoimmune diseases; Research and development services in the field of medical preparations; Technological research in the field of autoimmune and inflammatory diseases, cardiovascular diseases and infectious diseases; Pathological testing for medical research purposes; Providing medical research information in the field of pharmaceuticals; Providing medical and scientific research information; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing information about medical research; Providing information about medical research in the field of autoimmune diseases, immuno-cardiology, chronic inflammations, heart diseases, and new therapies for autoimmune diseases; Scientific research for medical purposes in the field of autoimmune diseases, immuno-cardiology, chronic inflammations, heart diseases, and new therapies for autoimmune diseases

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 7, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 7, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 23, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2025 NWOS
NEW APPLICATION ENTERED
Dec 30, 2024 NWAP